+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alopecia Treatment Market - Global Forecast 2026-2032- Product Image
Alopecia Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Alopecia Treatment Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305520
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Alopecia Treatment Market is projected to reach USD 12.93 Billion in 2026. It is expected to continue growing at a CAGR of 8.37%, reaching USD 21.06 Billion by 2032.

Alopecia treatment is moving from cosmetic hair restoration toward evidence-based dermatology, immunology, and regenerative medicine. Demand is anchored by the high burden of androgenetic alopecia, alopecia areata, telogen effluvium, traction alopecia, and scarring alopecias, with alopecia areata widely reported in peer-reviewed literature to affect approximately 2% of people over a lifetime. This creates sustained need for prescription hair loss therapies, over-the-counter products, device-based treatments, procedural solutions, and long-term disease management.

The market is increasingly shaped by clinically validated options. Topical minoxidil remains a core U.S. FDA-approved therapy for pattern hair loss, oral finasteride is established for male androgenetic alopecia, and Janus kinase inhibitors have changed expectations in severe alopecia areata following U.S. FDA approvals of baricitinib, ritlecitinib, and deuruxolitinib. Alongside these therapies, platelet-rich plasma, low-level laser devices, hair transplantation, topical antiandrogens, and emerging biologic and regenerative approaches are expanding the competitive landscape.

Transformative Shifts in Hair Loss Therapeutics

The alopecia treatment landscape is undergoing a structural shift from symptom masking to targeted intervention. The approval of systemic JAK inhibitors for severe alopecia areata has created a new benchmark for efficacy, safety monitoring, patient selection, and payer scrutiny. This is accelerating investment in immunology-focused pipelines, topical JAK formulations, prostaglandin pathways, Wnt signaling, follicle regeneration, and combination regimens.

Consumer behavior is also changing. Patients increasingly seek dermatology-led diagnosis before self-treatment, while teledermatology, direct-to-consumer hair loss platforms, and pharmacy-based access are widening treatment entry points. However, adoption remains constrained by variable reimbursement, long treatment timelines, adherence challenges, relapse risk after discontinuation, and the need to differentiate evidence-based hair regrowth therapies from cosmetic claims.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler across alopecia diagnosis, clinical development, and commercial execution. AI-enabled image analysis can help standardize scalp photography, hair density assessment, Severity of Alopecia Tool scoring support, and longitudinal response tracking. These tools are especially valuable because alopecia outcomes often depend on subtle changes in hair count, shaft diameter, coverage, and patient-reported quality of life.

AI is also improving trial feasibility by identifying eligible patient cohorts, reducing variability in endpoint assessment, and supporting real-world evidence generation from dermatology practices and digital health platforms. For manufacturers and providers, AI-driven personalization can support therapy selection based on alopecia subtype, disease duration, comorbid autoimmune conditions, contraindications, adherence patterns, and predicted response, while remaining dependent on strong privacy controls, bias monitoring, transparent validation, and clinician oversight.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is a high-opportunity arena for alopecia treatment because of large patient populations, rising dermatology access, strong aesthetic medicine adoption, and expanding medical tourism in hair restoration. China, India, Japan, South Korea, and Australia combine demand for prescription therapies with rapid adoption of cosmeceuticals, laser devices, platelet-rich plasma, and hair transplantation, although pricing sensitivity, uneven insurance coverage, and regulatory diversity remain important. Japan and Australia are characterized by stronger clinical governance, while South Korea’s advanced aesthetics ecosystem supports high patient awareness and early interest in procedural and device-based options.

North America leads in innovation, diagnosis rates, specialist access, and uptake of novel systemic therapies, supported by U.S. FDA approvals, mature dermatology networks, clinical trial activity, and telehealth-enabled care models. Europe benefits from structured healthcare systems, strong clinical governance, and pharmacovigilance standards, while health technology assessment and reimbursement evaluation can slow adoption of premium therapies. Latin America shows rising demand in Brazil and Mexico, particularly for aesthetic and procedural solutions, retail hair loss products, and private dermatology services. The Middle East, led by GCC economies, is expanding premium dermatology, aesthetic medicine, and transplant services through private healthcare investment and medical tourism, while Africa remains an emerging market where access, affordability, specialist availability, and public health priorities shape adoption of alopecia treatment.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN presents a diverse opportunity for alopecia treatment, with urban consumers in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines increasingly using dermatology clinics, aesthetic centers, pharmacies, and digital channels. Demand patterns vary by income level, urban access, and regulatory pathways, making localized education and channel strategy important. The GCC is positioned as a premium-care market, where private healthcare investment, medical tourism, high disposable income segments, and demand for hair transplantation support higher-value dermatology and aesthetic offerings.

The European Union emphasizes evidence, pharmacovigilance, clinical guidelines, and reimbursement discipline, making it attractive for clinically differentiated therapies with strong safety data and real-world outcome evidence. BRICS markets offer scale, expanding healthcare infrastructure, local manufacturing capabilities, and rising middle-class demand, but require country-specific pricing, access, and regulatory strategies. G7 countries remain central to innovation, regulatory precedent, clinical research, digital health adoption, and premium therapy uptake. NATO member markets overlap heavily with high-income healthcare systems across North America and Europe, creating demand for reliable supply chains, cybersecurity, resilient clinical infrastructure, and compliant digital health tools used in alopecia diagnosis and treatment monitoring.

Key Country Insights for Major Alopecia Treatment Markets

The United States is the most influential country for advanced alopecia treatment because U.S. FDA approvals, high specialist density, telehealth adoption, patient awareness, and direct-to-consumer channels accelerate uptake of prescription, OTC, device, and procedural solutions. Canada follows evidence-based adoption patterns with provincial access considerations and strong dermatology standards, while Mexico combines retail affordability, cross-border care dynamics, and rising procedural demand. Brazil is a major aesthetic medicine market, supporting strong interest in hair restoration, platelet-rich plasma, and dermatology-led hair loss therapies.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show consistent demand for clinically supported alopecia therapies, with Germany and France emphasizing reimbursement evidence and clinical value, and the U.K. balancing National Health Service pathways with private dermatology. Italy and Spain have well-developed aesthetic medicine cultures that support procedural and device-based care, while Russia remains shaped by local access, regulatory, and supply considerations. China and India offer scale and fast-growing consumer demand driven by urbanization, digital health adoption, and increasing awareness of androgenetic alopecia and alopecia areata. Japan and South Korea bring advanced dermatology, cosmetics science, and aesthetics expertise, while Australia has strong specialist care, regulatory standards, and early adoption of evidence-based hair loss treatments.

Actionable Recommendations for Alopecia Treatment Leaders

Industry leaders should prioritize differentiated evidence, not broad hair growth claims. Successful organizations will invest in robust clinical endpoints, long-term safety data, relapse monitoring, standardized photography, patient-reported outcomes, and real-world evidence that demonstrate measurable benefit across alopecia areata, androgenetic alopecia, telogen effluvium, traction alopecia, and scarring alopecias.

Manufacturers should build segmented access strategies for prescription therapies, OTC products, devices, and procedures. Dermatology partnerships, AI-enabled monitoring, patient adherence programs, and payer-ready outcomes data can improve persistence and reimbursement. Organizations should also localize pricing, education, and distribution by region, while maintaining transparent safety communication for systemic immunomodulators, hormonal therapies, and long-duration treatment pathways.

Research Methodology

This executive summary is developed through a structured research approach combining secondary research, expert interpretation, and data triangulation. Sources considered include regulatory approvals, dermatology guidelines, peer-reviewed literature, clinical trial registries, public health data, drug labels, reimbursement references, and regional healthcare access indicators.

The methodology emphasizes validated evidence over promotional claims. Market signals are assessed across treatment class, alopecia subtype, route of administration, patient access, regional regulation, reimbursement environment, safety requirements, digital health adoption, and competitive innovation. Insights are cross-checked to support strategic decision-making for pharmaceutical manufacturers, medical device developers, dermatology providers, investors, payers, and healthcare stakeholders.

Conclusion: Evidence-Based Advancement in Alopecia Treatment

The alopecia treatment market is entering a more clinically sophisticated phase. Established therapies such as minoxidil and finasteride continue to anchor treatment pathways, while JAK inhibitors and emerging targeted approaches are redefining expectations for severe alopecia areata and immune-mediated hair loss. Procedural solutions, platelet-rich plasma, low-level laser therapy, and hair transplantation continue to support patient demand where evidence, provider expertise, and appropriate selection are strong.

Future advancement will depend on durable efficacy, safety confidence, affordability, personalization, and measurable patient outcomes. Organizations that combine scientific credibility, regional access discipline, AI-enabled monitoring, and patient-centered care models will be best positioned to lead the next phase of global hair loss treatment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Alopecia Treatment Market, by Treatment Type
7.1. Introduction
7.2. Injectable Therapies
7.2.1. Corticosteroid Injections
7.2.2. Platelet Rich Plasma
7.3. Laser Therapy
7.3.1. Hair Growth Devices
7.3.2. Low Level Laser Therapy
7.4. Oral Therapies
7.4.1. Dutasteride
7.4.2. Finasteride
7.4.3. Spironolactone
7.5. Surgical Treatments
7.5.1. Hair Transplantation
7.5.2. Scalp Micropigmentation
7.6. Topical Therapies
7.6.1. Corticosteroids
7.6.2. Minoxidil
8. Alopecia Treatment Market, by Alopecia Type
8.1. Introduction
8.2. Alopecia Areata
8.2.1. Patchy
8.2.2. Totalis
8.2.3. Universalis
8.3. Androgenetic Alopecia
8.3.1. Female Pattern
8.3.2. Male Pattern
8.4. Scarring Alopecia
8.5. Telogen Effluvium
8.6. Traction Alopecia
9. Alopecia Treatment Market, by Technology
9.1. Introduction
9.2. Low Level Laser Therapy
9.3. Platelet Rich Plasma
9.4. Stem Cell Therapy
9.4.1. Autologous Hair Follicle
9.4.2. Mesenchymal Stem Cell
10. Alopecia Treatment Market, by Age Group
10.1. Introduction
10.2. Adolescent
10.3. Adult
10.4. Geriatric
11. Alopecia Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Alopecia Treatment Market, by End User
12.1. Introduction
12.2. Hospitals
12.3. Specialty Clinics
12.4. Home Care Setting
12.5. Research Institutions
13. Alopecia Treatment Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Alopecia Treatment Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Alopecia Treatment Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AbbVie Inc.
17.2. Aclaris Therapeutics, Inc.
17.3. Almirall, S.A.
17.4. Amorepacific Corporation
17.5. Bayer AG
17.6. Capillus, LLC
17.7. Cipla Limited
17.8. Concert Pharmaceuticals, Inc.
17.9. Daiichi Sankyo Company, Limited
17.10. Dr. Reddy's Laboratories Ltd.
17.11. Eli Lilly and Company
17.12. Giuliani S.p.A.
17.13. GlaxoSmithKline plc
17.14. Johnson & Johnson Services, Inc.
17.15. Kao Corporation
17.16. L'Oréal S.A.
17.17. Merck & Co., Inc.
17.18. Pfizer Inc.
17.19. Pierre Fabre Laboratories
17.20. Shiseido Company, Limited
17.21. Sun Pharmaceutical Industries Ltd.
17.22. Taisho Pharmaceutical Holdings Co., Ltd.
17.23. Takeda Pharmaceutical Company Limited
17.24. The Estée Lauder Companies Inc.
17.25. The Procter & Gamble Company
17.26. Theradome Inc.
17.27. Unilever PLC
List of Figures
FIGURE 1. GLOBAL ALOPECIA TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ALOPECIA TREATMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CORTICOSTEROID INJECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CORTICOSTEROID INJECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CORTICOSTEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LASER THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LASER THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LASER THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HAIR GROWTH DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HAIR GROWTH DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HAIR GROWTH DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ORAL THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ORAL THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ORAL THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DUTASTERIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DUTASTERIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DUTASTERIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL FINASTERIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SPIRONOLACTONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SPIRONOLACTONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SPIRONOLACTONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HAIR TRANSPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HAIR TRANSPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HAIR TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SCALP MICROPIGMENTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SCALP MICROPIGMENTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SCALP MICROPIGMENTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MINOXIDIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MINOXIDIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MINOXIDIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ALOPECIA AREATA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ALOPECIA AREATA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ALOPECIA AREATA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PATCHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PATCHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PATCHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TOTALIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TOTALIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TOTALIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL UNIVERSALIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL UNIVERSALIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL UNIVERSALIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ANDROGENETIC ALOPECIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ANDROGENETIC ALOPECIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ANDROGENETIC ALOPECIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FEMALE PATTERN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL FEMALE PATTERN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL FEMALE PATTERN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL MALE PATTERN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MALE PATTERN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MALE PATTERN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SCARRING ALOPECIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SCARRING ALOPECIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SCARRING ALOPECIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TELOGEN EFFLUVIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TELOGEN EFFLUVIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TELOGEN EFFLUVIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TRACTION ALOPECIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL TRACTION ALOPECIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL TRACTION ALOPECIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LOW LEVEL LASER THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL AUTOLOGOUS HAIR FOLLICLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL AUTOLOGOUS HAIR FOLLICLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AUTOLOGOUS HAIR FOLLICLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ADOLESCENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ADOLESCENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ADOLESCENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL HOME CARE SETTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL HOME CARE SETTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL HOME CARE SETTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 147. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 148. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 149. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 150. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 151. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 152. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 154. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 155. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 157. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 158. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 159. EUROPE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 192. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 193. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 194. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 195. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 196. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 197. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 198. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 199. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 200. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 202. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 203. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. NATO ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. NATO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 223. NATO ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 224. NATO ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 225. NATO ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 226. NATO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 227. NATO ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 228. NATO ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 229. NATO ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 230. NATO ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 231. NATO ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 232. NATO ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 233. NATO ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 234. NATO ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 235. NATO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. G7 ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. G7 ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 238. G7 ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 239. G7 ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 240. G7 ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 241. G7 ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 242. G7 ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 243. G7 ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 244. G7 ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 245. G7 ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 246. G7 ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 247. G7 ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 248. G7 ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 249. G7 ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. G7 ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. BRICS ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 252. BRICS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 253. BRICS ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 254. BRICS ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 255. BRICS ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 256. BRICS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 257. BRICS ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 258. BRICS ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 259. BRICS ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 260. BRICS ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 261. BRICS ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 262. BRICS ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 263. BRICS ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 264. BRICS ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 265. BRICS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 282. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 283. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 284. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 285. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 286. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 287. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 288. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 289. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 290. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 291. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 292. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 293. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 294. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. ASEAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. GCC ALOPECIA TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 297. GCC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 298. GCC ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 299. GCC ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 300. GCC ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 301. GCC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 302. GCC ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 303. GCC ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 304. GCC ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 305. GCC ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 306. GCC ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. GCC ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 308. GCC ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 309. GCC ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. GCC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 312. CHINA ALOPECIA TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 314. CHINA ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 315. CHINA ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 316. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 317. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 318. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 319. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 320. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 321. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 322. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. CHINA ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 324. CHINA ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 325. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 338. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 339. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 340. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 341. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 342. JAPAN ALOPECIA TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 343. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 344. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 345. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 346. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 347. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 348. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 349. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TYPE, 2017-2032 (USD MILLION)
TABLE 350. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, 2017-2032 (USD MILLION)
TABLE 351. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, 2017-2032 (USD MILLION)
TABLE 352. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 353. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2017-2032 (USD MILLION)
TABLE 354. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 355. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 356. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 357. INDIA ALOPECIA TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 358. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 359. INDIA ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE THERAPIES, 2017-2032 (USD MILLION)
TABLE 360. INDIA ALOPECIA TREATMENT MARKET SIZE, BY LASER THERAPY, 2017-2032 (USD MILLION)
TABLE 361. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 362. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, 2017-2032 (USD MILLION)
TABLE 363. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 364. INDIA ALOP

Companies Mentioned

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • Almirall, S.A.
  • Amorepacific Corporation
  • Bayer AG
  • Capillus, LLC
  • Cipla Limited
  • Concert Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Giuliani S.p.A.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Kao Corporation
  • L'Oréal S.A.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Pierre Fabre Laboratories
  • Shiseido Company, Limited
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • The Estée Lauder Companies Inc.
  • The Procter & Gamble Company
  • Theradome Inc.
  • Unilever PLC

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 12.93 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.06 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Alopecia Drugs Market - Global Forecast 2026-2032 - Product Image

Alopecia Drugs Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Alopecia Treatment Market Size, Share, Trends and Forecast by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region, 2026-2034 - Product Image

Alopecia Treatment Market Size, Share, Trends and Forecast by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region, 2026-2034

  • Report
  • 146 Pages
  • Global
From
Androgenetic Alopecia Treatment Market Report 2026 - Product Image

Androgenetic Alopecia Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Alopecia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Alopecia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Alopecia Market Report 2026 - Product Image

Alopecia Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.